QuidelOrtho (QDEL)
(Delayed Data from NSDQ)
$41.05 USD
-0.92 (-2.19%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $41.04 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$41.05 USD
-0.92 (-2.19%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $41.04 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth C Momentum C VGM
Zacks News
Here's Why You Should Retain QuidelOrtho (QDEL) Stock For Now
by Zacks Equity Research
Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.
Quidel (QDEL) Q1 Earnings, Revenues Surpass Estimates, Up Y/Y
by Zacks Equity Research
Quidel's (QDEL) robust performance across two of its product categories drives its first-quarter 2022 top line.
Quidel (QDEL) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Quidel (QDEL) delivered earnings and revenue surprises of 25.65% and 21.77%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Medical Product Stocks' Earnings May 5 Roster: MCK, CAH & PODD
by Debanjana Dey
The Medical Product companies' quarterly results are likely to reflect base business recovery. Let's see how MCK, CAH and PODD are poised ahead of their earnings releases.
Quidel (QDEL) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Quidel's (QDEL) first-quarter results are likely to reflect continued strength across its SARS-related products.
Quidel (QDEL) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Quidel (QDEL) closed at $104.52 in the latest trading session, marking a -1.32% move from the prior day.
Quidel (QDEL) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Quidel (QDEL) closed at $113.95, marking a +1.29% move from the previous day.
Quidel (QDEL) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Quidel (QDEL) closed at $112.50, marking a -0.51% move from the previous day.
Quidel Corporation (QDEL) Reports Solid Preliminary Q1 Revenues
by Zacks Equity Research
Quidel's (QDEL) revenue growth in the first quarter is likely to have been boosted by continued robust sales of its SARS-related products.
Quidel (QDEL) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Quidel (QDEL) closed at $114.15 in the latest trading session, marking a -1.17% move from the prior day.
Here's How Much You'd Have If You Invested $1000 in Quidel a Decade Ago
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Quidel (QDEL) Stock Moves -0.3%: What You Should Know
by Zacks Equity Research
Quidel (QDEL) closed the most recent trading day at $112.46, moving -0.3% from the previous trading session.
Quidel (QDEL) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Quidel (QDEL) closed the most recent trading day at $109.20, moving -1.13% from the previous trading session.
Quidel (QDEL) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Quidel (QDEL) closed at $112.17, marking a -1.71% move from the previous day.
Encompass Health's (EHC) Nationwide Hospital Count Rises to 147
by Zacks Equity Research
Encompass Health (EHC) opens a 60-bed inpatient rehabilitation hospital in Illinois, sustaining its aim to offer enhanced rehabilitation services throughout the United States.
UnitedHealth Group (UNH) Gains 38% in a Year: More Room to Run?
by Zacks Equity Research
Continued revenue growth, management optimism surrounding the Medicaid business, several contract wins, and solid cash balance continue to drive UnitedHealth Group (UNH).
Quidel (QDEL) Crossed Above the 50-Day Moving Average: What That Means for Investors
by Zacks Equity Research
When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?
Quidel (QDEL) Just Reclaimed the 20-Day Moving Average
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Here's How Much a $1000 Investment in Quidel Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Quidel (QDEL) Stock Moves -0.29%: What You Should Know
by Zacks Equity Research
Quidel (QDEL) closed the most recent trading day at $99.20, moving -0.29% from the previous trading session.
Zacks.com featured highlights include Sanderson Farms, Quidel, Crown Holdings, Everest Re Group and Eversource Energy
by Zacks Equity Research
Sanderson Farms, Quidel, Crown Holdings, Everest Re Group and Eversource Energy are included in this blog.
Wall Street Analysts Think Quidel (QDEL) Could Surge 52%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 52.1% upside potential for Quidel (QDEL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Reasons to Add Quidel (QDEL) Stock To Your Portfolio Now
by Zacks Equity Research
Investors continue to be optimistic about Quidel (QDEL) owing to its strong diagnostics portfolio.
5 Stocks With Solid Sales Growth to Buy Amid Market Volatility
by Swayta Shah
Steady sales growth is vital to gauge a company's health and ability to sustain its business. Let's check out Sanderson Farms (SAFM), Quidel (QDEL), Crown Holdings (CCK), Everest Re (RE) and Eversource Energy (ES) that are witnessing top-line growth.
Should Value Investors Buy These Medical Stocks?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.